ProShare Advisors
BLUE

ProShare Advisors’s bluebird bio BLUE Stock Holding History

ProShare Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,373
Closed -$24.7K – 2277
2024
Q3 		$24.7K Buy
2,373
+503
+27% +$8.36K ﹤0.01% 2035
2024
Q2 		$36.8K Sell
1,870
-517
-22% -$10.4K ﹤0.01% 1774
2024
Q1 		$61.1K Buy
2,387
+1,152
+93% +$29.5K ﹤0.01% 1879
2023
Q4 		$34.1K Buy
1,235
+190
+18% +$11.6K ﹤0.01% 1894
2023
Q3 		$63.5K Buy
1,045
+5
+0.5% +$351 ﹤0.01% 1694
2023
Q2 		$68.4K Buy
1,040
+77
+8% +$5.63K ﹤0.01% 1743
2023
Q1 		$61.3K Buy
963
+86
+10% +$9.82K ﹤0.01% 1652
2022
Q4 		$121K Buy
877
+127
+17% +$17.9K ﹤0.01% 1610
2022
Q3 		$95K Buy
750
+70
+10% +$7.92K ﹤0.01% 1568
2022
Q2 		$56K Sell
680
-316
-32% -$24.5K ﹤0.01% 1692
2022
Q1 		$96K Sell
996
-236
-19% -$31.1K ﹤0.01% 2040
2021
Q4 		$247K Sell
1,232
-551
-31% -$130K ﹤0.01% 1902
2021
Q3 		$441K Sell
1,783
-694
-28% -$198K ﹤0.01% 1282
2021
Q2 		$1.03M Buy
2,477
+1,663
+204% +$659K ﹤0.01% 1024
2021
Q1 		$318K Sell
814
-69
-8% -$34K ﹤0.01% 1772
2020
Q4 		$495K Sell
883
-29
-3% -$18.4K ﹤0.01% 1283
2020
Q3 		$638K Buy
912
+33
+4% +$25.7K ﹤0.01% 854
2020
Q2 		$695K Buy
879
+213
+32% +$161K ﹤0.01% 816
2020
Q1 		$397K Sell
666
-360
-35% -$351K ﹤0.01% 791
2019
Q4 		$1.17M Sell
1,026
-229
-18% -$249K 0.01% 753
2019
Q3 		$1.49M Sell
1,255
-90
-7% -$137K 0.01% 651
2019
Q2 		$2.22M Sell
1,345
-266
-17% -$460K 0.01% 567
2019
Q1 		$3.28M Buy
1,611
+55
+4% +$96.8K 0.02% 491
2018
Q4 		$2M Sell
1,556
-290
-16% -$445K 0.01% 572
2018
Q3 		$3.49M Buy
1,846
+128
+7% +$264K 0.02% 505
2018
Q2 		$3.49M Sell
1,718
-648
-27% -$1.48M 0.02% 512
2018
Q1 		$5.23M Sell
2,366
-203
-8% -$516K 0.03% 429
2017
Q4 		$5.93M Buy
2,569
+260
+11% +$528K 0.04% 391
2017
Q3 		$4.11M Buy
2,309
+341
+17% +$476K 0.04% 416
2017
Q2 		$2.68M Sell
1,968
-144
-7% -$174K 0.03% 492
2017
Q1 		$2.49M Sell
2,112
-340
-14% -$347K 0.03% 497
2016
Q4 		$1.96M Buy
2,452
+281
+13% +$223K 0.02% 557
2016
Q3 		$1.91M Sell
2,171
-396
-15% -$287K 0.03% 508
2016
Q2 		$1.44M Buy
2,567
+395
+18% +$224K 0.02% 616
2016
Q1 		$1.2M Sell
2,172
-211
-9% -$130K 0.02% 644
2015
Q4 		$1.98M Buy
2,383
+146
+7% +$146K 0.02% 510
2015
Q3 		$2.48M Buy
2,237
+212
+10% +$387K 0.03% 420
2015
Q2 		$4.42M Sell
2,025
-369
-15% -$752K 0.06% 297
2015
Q1 		$3.75M Buy
2,394
+559
+30% +$738K 0.04% 374
2014
Q4 		$2.18M Buy
1,835
+30
+2% +$20K 0.03% 542
2014
Q3 		$839K Sell
1,805
-61
-3% -$28.1K 0.01% 1135
2014
Q2 		$932K Sell
1,866
-73
-4% -$23.4K 0.01% 1188
2014
Q1 		$571K Buy
1,939
+1,095
+130% +$332K 0.01% 1764
2013
Q4 		$229K Buy
+844
New +$236K ﹤0.01% 1232

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

ProShare Advisors's BLUE Position: Q4 2024 in Review

ProShare Advisors sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 2,373 shares — an estimated $24.7K sold.

ProShare Advisors first reported a position in BLUE in Q4 2013 and held it in 44 quarters. The position peaked at $5.93M in Q4 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • ProShare Advisors reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • ProShare Advisors sold 2,373 bluebird bio shares in Q4 2024, an estimated $24.7K.
  • ProShare Advisors first reported a position in bluebird bio in Q4 2013 and held it in 44 quarters.
  • ProShare Advisors's bluebird bio position peaked at $5.93M in Q4 2017.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.